Navigation Links
Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results
Date:8/21/2008

,446) - - 8,101,306 6,075,860

Income tax

(benefit)

expense (930,480) - - 2,702,892 1,772,412

Net (loss)

income $(1,094,966) $- $- $5,398,414 $4,303,448

Basic (loss)

earnings per

share $(0.09) $- $- $0.47 $0.37

Diluted (loss)

earnings per

share $(0.09) $- $- $0.44 $0.35

Weighted

average

common shares

outstanding 11,608,026 11,608,026 11,608,026 11,608,026 11,608,026

Diluted

weighted

average

common

shares

outstanding 12,163,840 12,163,840 12,163,840 12,163,840 12,163,840

(Unaudited)

As Reported Non-GAAP Adjustments As Adjusted

Twelve Embolic One-Time Sale of Twelve

Months Protection Equity Endovas- Months

Ended Disconti- Accelera- cular Ended

June 30, nuance tion Business June 30,

2008 2008 2008 2008 2008

Revenues:

Net sales

Biomate-

rials $47,538,923 $- $- $- $47,538,923

Endovas-

cular 6,221,942 - - - 6,221,942

Total net

sales 53,760,865 - - - 53,760,865

Research

and

development - - - - -

Royalty

income 26,030,032 - - - 26,030,032

Total

revenues 79,790,897 - - - 79,790,897

Operating

costs and

ex
'/>"/>

SOURCE Kensey Nash Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related biology technology :

1. Kensey Nash Corporation Announces Its Third Quarter 2008 Earnings Release Date and Teleconference
2. Kensey Nash Receives FDA 510(k) Clearance for New Safe-Cross(R) Vessel Wall Detection Technology
3. Kensey Nash to Present at the Canaccord Adams Small-Cap Orthopedics Conference
4. Kensey Nash to Participate in the Sidoti Fifth Annual Palm Beach Emerging Growth Institutional Investor Forum Conference
5. Kensey Nash to Participate in the RBC Capital Markets Healthcare Conference
6. Kensey Nash to Present at the Sidoti Sixth Annual West Coast Emerging Growth Institutional Investor Forum Conference
7. InstaCare Corp. Continues Turnaround & Reports 291% Revenues Increase in 2Q 2008
8. CEL-SCI CORPORATION Reports Third Quarter 2008 Financial Results
9. Expert Neurology Panel Weighs Impact of New Reports of PML in Multiple Sclerosis Patients on Tysabri
10. Arpida Reports Interim Results for Six Months to 30 June 2008
11. Rosetta Genomics Reports Second Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... Paula, CA (PRWEB) September 15, 2014 ... long term implantable silicones for the medical device ... responsive silicone gel for the implantable medical device ... a unique crosslink technology delivering a silicone gel ... The Dual Matrix technology consists of two ...
(Date:9/15/2014)... 15 septembre 2014 La deuxième édition ... (semaine internationale sur la sensibilisation au plasma) ... conjointe de la Plasma Protein Therapeutics Association ... , l,IPAW vise à : , ... la collecte du plasma-aphérèse , Reconnaître la ...
(Date:9/15/2014)... 2014  The second annual International Plasma Awareness ... joint initiative of the Plasma Protein Therapeutics Association ... is designed to: , Raise global awareness ... of plasma donors in saving and improving lives ... rare diseases Member companies are planning ...
(Date:9/14/2014)... (PRWEB) September 15, 2014 UMBC’s ... held on Tuesday, October 21, 2014, from 12:00 to ... of the program’s innovative curriculum and practice-oriented instruction, designed ... graduate degree can help advance their career in the ... RSVP online . , About UMBC’s Biotechnology Graduate ...
Breaking Biology Technology:Applied Silicone Launches Silicone Gel System with Dual Matrix Technology 2L' International Plasma Awareness Week célébrera les donneurs et braquera les projecteurs sur les maladies rares 2L' International Plasma Awareness Week célébrera les donneurs et braquera les projecteurs sur les maladies rares 3International Plasma Awareness Week To Celebrate Donors And Spotlight Rare Diseases 2International Plasma Awareness Week To Celebrate Donors And Spotlight Rare Diseases 3UMBC Biotechnology Graduate Programs’ Virtual Info Session, October 21, 2014 2
... ... management, NEW ... CAXG), which has the largest,manufacturing facility and product pipeline for highly ... China,State Food & Drug Administration (SFDA) granted the Company the designated,manufacturer ...
... ROCKVILLE, Md., Nov. 26 Human Genome,Sciences, Inc. (Nasdaq: ... the,Piper Jaffray 19th Annual Health Care Conference will be ... (Logo: http://www.newscom.com/cgi-bin/prnh/20010612/HGSLOGO ), A member of ... of the company on Wednesday, November 28, 2007 at ...
... Ability to Integrate with Multiple Disparate PACS ... ... Turnaround, CHICAGO, Nov. 26 RSNA Booth #5924 ... connectivity and,interoperability between diagnostic acquisition devices, PACS, HIS, RIS,and ...
Cached Biology Technology:China Aoxing Pharmaceutical Designated as a Key Manufacturer of Cancer Pain Drug by China SFDA 2China Aoxing Pharmaceutical Designated as a Key Manufacturer of Cancer Pain Drug by China SFDA 3China Aoxing Pharmaceutical Designated as a Key Manufacturer of Cancer Pain Drug by China SFDA 4E-Rad Solutions Selects Compressus' Enterprise Systems Integration Technology to Fuel Entry Into Teleradiology Market 2E-Rad Solutions Selects Compressus' Enterprise Systems Integration Technology to Fuel Entry Into Teleradiology Market 3
(Date:9/15/2014)... Earth for the first 500 million years after it ... day, complete with oceans, continents and active crustal plates. ... called the Hadean, has gained substantial new support from ... more than 4 billion years ago with those formed ... possible geological analog for early Earth. , The study ...
(Date:9/15/2014)... of the cheetah: The big predator is the fastest land ... just a few seconds. As it ramps up to top ... it reaches a full gallop. , Now MIT researchers have ... a robotic cheetah a sleek, four-legged assemblage of gears, ... its feline counterpart. The team recently took the robot for ...
(Date:9/15/2014)... wild, domesticated, and domesticated-wild hybridized populations of ... that within 5 to 11 generations, selection ... populations that hybridized with domesticated populations. , ... evidence that natural selection, over time, removes ... as a result of increased genetic diversity. ...
Breaking Biology News(10 mins):Early Earth less hellish than previously thought 2Early Earth less hellish than previously thought 3Run, cheetah, run 2Run, cheetah, run 3
... a multi-institutional study led by Cincinnati Childrens Hospital ... stubborn solid tumor cancers neuroblastoma and peripheral ... inserting instructions to inhibit tissue growth into an ... the February 15 Cancer Research. Malignant ...
... a one-celled, planktonic marine organism, reported today (Thursday, ... telling scientists about the evolutionary changes that accompanied ... animals like ourselves. In the Nature paper ... week, University of California, Berkeley, biologists Nicole King, ...
... the ideal environmentally friendly energy source, it would be a ... that does not pollute our air when burned. That is ... in a new program that uses bacteria and sunlight to ... The project is one of the first to ...
Cached Biology News:Tumor-targeting viral therapy slows neuroblastoma, malignant peripheral nerve sheath tumors 2Genome of marine organism tells of humans' unicellular ancestors 2Genome of marine organism tells of humans' unicellular ancestors 3Genome of marine organism tells of humans' unicellular ancestors 4Project focuses on production of hydrogen from bacteria and sunlight 2Project focuses on production of hydrogen from bacteria and sunlight 3Project focuses on production of hydrogen from bacteria and sunlight 4
Human Glypican 2 Biotinylated Affinity Purified PAb...
Human Contactin-2/TAG1 Affinity Purified Polyclonal Ab...
Tachykinin (H-2)...
Human BMP 2 Construction Kit provides antigen affinity purified polyclonal capture and tracer antibodies, and antigen standard for development of approximately ten microplate assays....
Biology Products: